https://www.avient.com/sites/default/files/2024-06/CM Europe Ltd Modern_Slavery_Statement - 2024 V4.pdf
Avient and its global direct and indirect subsidiaries and affiliates, including ColorMatrix (“Avient”), are intermediate suppliers of
specialty polymers and related raw materials designed to meet the specifications of its manufacturing customers.
https://www.avient.com/sites/default/files/2021-01/sem-base-station-antenna-application-bulletin.pdf
HOW AVIENT CUSTOM POLYMER FORMULATIONS MAKE THE DIFFERENCE FOR 5G BASE
STATION ANTENNA PHASE SHIFTS
Faster Design Qualification & Shorter Lead
Times – Avient can custom formulate materials
to specific Dk values, sample within one week,
and deliver on production quantities within two
to three weeks.
Low Dissipation Factor (Df) Material – Our
solutions use a base formulation that has a Df
value of less than 0.002.
Good Dimensional Stability – Our solutions are
formulated to meet dimensional tolerances within
+/- 0.2mm.
https://www.avient.com/sites/default/files/2021-04/avnt-fourth-quarter-2020-news-release.pdf
NEWS RELEASE
FOR IMMEDIATE RELEASE
Avient Announces Fourth Quarter and Full Year 2020 Results
and Provides Guidance for 2021
Fourth Quarter Results
• GAAP EPS from continuing operations of $0.81 compared to $0.08 in the prior year quarter
• Record fourth quarter adjusted EPS of $0.52 increased 73% compared to $0.30 pro forma*
in the prior year, driven by strong organic revenue growth in all segments, improved
operating margins and synergy capture from the Clariant Masterbatch acquisition
• Increased dividend for the 10th consecutive year to $0.85 a share on an annualized basis
Full Year Results
• Completed transformational Clariant Masterbatch acquisition and renamed the company as
Avient
• GAAP EPS from continuing operations of $1.46 compared to $0.97 in the prior year
• Adjusted EPS increased 11% to $1.93 pro forma, on strength in healthcare, packaging and
consumer end markets
• Specialty Engineered Materials (SEM) segment delivered record operating income of $94
million, driven by growth in composites and demand for outdoor high performance
applications
CLEVELAND – February 9, 2021 – Avient Corporation (NYSE: AVNT), a leading provider of
specialized and sustainable material solutions, today reported its full year and fourth quarter
results for 2020.
Factors
that could cause actual results to differ materially from those implied by these forward-looking
statements include the impact the COVID-19 pandemic has on our business, results from
operations, financial condition and liquidity; our ability to achieve the strategic and other
objectives relating to the acquisition of Clariant’s Masterbatch business, including any expected
synergies; disruptions, uncertainty or volatility in the credit markets that could adversely impact
the availability of credit already arranged and the availability and cost of credit in the future; the
effect on foreign operations of currency fluctuations, tariffs and other political, economic and
regulatory risks; changes in polymer consumption growth rates and laws and regulations
regarding plastics in jurisdictions where we conduct business; changes in global industry
capacity or in the rate at which anticipated changes in industry capacity come online;
fluctuations in raw material prices, quality and supply, and in energy prices and supply;
production outages or material costs associated with scheduled or unscheduled maintenance
programs; unanticipated developments that could occur with respect to contingencies such as
litigation and environmental matters; our ability to continue to pay cash dividends including at
the increased rate; an inability to raise or sustain prices for products or services; an ability to
achieve or delays in achieving or achievement of less than the anticipated financial benefit from
initiatives related to acquisitions and integration, working capital reductions, costs reductions
and employee productivity goals; information systems failures and cyberattacks; and other
factors affecting our business beyond our control, including, without limitation, changes in the
general economy, changes in interest rates and changes in the rate of inflation.
Three Months Ended
Year Ended
Sales:
Color, Additives and Inks $ 525.8 $ 226.7 $ 1,502.9 $ 1,003.8
Specialty Engineered Materials 190.6 177.5 708.8 745.7
Distribution 305.1 272.4 1,110.3 1,192.2
Corporate and eliminations (24.5) (18.0) (79.9) (79.0)
Sales $ 997.0 $ 658.6 $ 3,242.1 $ 2,862.7
Gross margin:
Color, Additives and Inks $ 164.3 $ 73.9 $ 484.4 $ 338.4
Specialty Engineered Materials 59.1 47.7 207.6 200.2
Distribution 32.4 31.0 124.0 132.1
Corporate and eliminations (2.9) 0.7 (31.7) (13.5)
Gross margin $ 252.9 $ 153.3 $ 784.3 $ 657.2
Selling and administrative expense:
Color, Additives and Inks $ 106.8 $ 46.7 $ 303.6 $ 191.0
Specialty Engineered Materials 28.7 28.9 113.2 116.5
Distribution 14.4 14.0 54.5 56.7
Corporate and eliminations 38.0 43.2 123.7 136.2
Selling and administrative expense $ 187.9 $ 132.8 $ 595.0 $ 500.4
Operating income:
Color, Additives and Inks $ 57.5 $ 27.2 $ 180.8 $ 147.4
Specialty Engineered Materials 30.4 18.8 94.4 83.7
Distribution 18.0 17.0 69.5 75.4
Corporate and eliminations (40.9) (42.5) (155.4) (149.7)
Operating income $ 65.0 $ 20.5 $ 189.3 $ 156.8
11
Attachment 7
Reconciliation of Non-GAAP Financial Measures (Unaudited)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current
profitability levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/2024-08/Cesa Non-PFAS Blown Film Snapshot.pdf
FILM
MANUFACTURER
B L O W N F I L M
• Maintain comparable performance to PFAS additives
• Meet regulatory compliance
• Eliminate melt fracture and reduce die buildup
• Increase productivity by reducing product changeover time
• Provided a non-PFAS formulation that met
all performance and regulatory requirements
and did not interact with other additives
• Helped eliminate melt fracture with a quick
time to clear of under forty minutes
• Delivered technical support, including
comprehensive testing on various
chemistries and polymers
• Attained high throughput with a minimal
amount of additive
Cesa™ Non-PFAS Process Aid for Extrusion
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/products/polymer-additives/processing-enhancement-additives/cesa-non-pfas-process-aid-extrusion
https://www.avient.com/sites/default/files/2024-05/Mevopur-Surgical Gown-Case study snapshot_0520.pdf
Medical textile manufacturer
LEARN MORE
MEDICAL TEXTILE
MANUFACTURER
S U R G I C A L D R A P E S & G O W N S
• Pre-tested for ISO 10993 biocompatibility standard
• Available in standard blue or other customized colors
• Compatible with ETO sterilization
• Suitable for use in non-woven SMS spunbond layer
• Offered standard blue and custom colors
such as green
• Pre-tested raw materials for biocompatibility
ISO10993 standard
• Manufactured under ISO 13485 certified
medical sites with change control in place
MevopurTM Healthcare Colorants and
Formulations
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/products/polymer-colorants/healthcare-colorants/mevopur-healthcare-colorants-and-formulations
Slide 1: Medical textile manufacturer